ALRN
Aileron Therapeutics, Inc.
No insider bought or sold Aileron Therapeutics, Inc. in the last 12 months
ALRN over the last year
Prices for ALRN aren't in yet.
ALRN after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
37 insider filings since 2017, newest first
University of Texas/Texas Am Investment Management Co · 10% owner
University of Texas/Texas Am Investment Management Co · 10% owner
University of Texas/Texas Am Investment Management Co · 10% owner
University of Texas/Texas Am Investment Management Co · 10% owner
Muneer A Satter · Insider
Rickenbach Josef H Von · Director
Kathryn Gregory · SVP and Chief Business Officer
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Scott Kapnick · Director and 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Apple Tree Partners II LP · 10% owner
Apple Tree Partners II LP · 10% owner
Apple Tree Partners II LP · 10% owner
Apple Tree Partners II LP · 10% owner
Apple Tree Partners II LP · 10% owner
Apple Tree Partners II LP · 10% owner
Apple Tree Partners II LP · 10% owner
Aju Ib Investment Co., Ltd. · 10% owner
Armen Shanafelt · Director
Lv Management Group, LLC · Former 10% owner
Brian M. Gallagher Jr. · Director
Sigma Emerging Markets Ltd. · 10% owner
Excel Medical Fund LP · 10% owner
Muneer A Satter · 10% owner
Kck Ltd. · 10% owner
Roche Holding Ltd · 10% owner
Cvf, LLC · 10% owner
Scott Kapnick · Director and 10% owner
Reinhard J. Ambros · Director
Novartis Bioventures Ltd · 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.